RecruitingNCT07504731

Trunk Inclination, Positive End-expiratory Pressure, and Lung Recruitability

Impact of Trunk Inclination on Lung Mechanics According to PEEP and Reruitability


Sponsor

Zhongda Hospital

Enrollment

40 participants

Start Date

Mar 20, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This multicenter, physiological, observational study hypothesizes that in moderate to severe ARDS, trunk inclination unloads the chest wall, but its impact on lung mechanics depends on PEEP levels and lung recruitability.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Specific lung recruitment maneuvers and decremental PEEP steps for people with acute respiratory distress syndrome (ards). The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSpecific lung recruitment maneuvers and decremental PEEP steps

Specific lung recruitment maneuvers will be performed to measure the potential for lung recruitment. Followed by a decremental PEEP steps to determine lung mechanics at different PEEP levels. These process will be repeated when patients change to another position. Electrical impedance tomography signals, synchronized signals of airway pressure and flow, esophageal pressure will be recorded continuously.


Locations(3)

Zhongda Hospital, Southeast University

Nanjing, Jiangsu, China

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital

Jinan, Shandong, China

West China Hospital of Sichuan University

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07504731


Related Trials